Transjugular Intrahepatic Portosystemic Shunt
Transjugular Intrahepatic Portosystemic Shunt is a medical procedure with 14 clinical trials. Currently 7 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
7
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Mechanism of TIPS to Improve Sarcopenia
VIATORR Device Registry
Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
TIPS for Platinum-Related Porto-Sinusoidal Vascular Disease With Variceal Bleeding
Clinical Trials (14)
Mechanism of TIPS to Improve Sarcopenia
VIATORR Device Registry
Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
TIPS for Platinum-Related Porto-Sinusoidal Vascular Disease With Variceal Bleeding
Clinical Study of PTFE Covered Stent for Treating Portal Hypertension
Dynamic Monitor of Portacaval Pressure Gradient
Standard Therapy and TIPS for Moderate to High-risk Esophageal and Gastric Variceal Bleeding
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure
Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.
Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome
All 14 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 14